Navigation Links
Moving from Treatment to Management: MassDevice Focuses On Chronic Diseases and the Future Business Model of Med-tech at the 2013 Big 100 West
Date:11/13/2013

(PRWEB) November 13, 2013

MassDevice, an online journal of the medical devices industry, is pleased to announce the 2013 MassDevice Big 100 West, an evening of insight into how decisions are made at the highest level of the medical device industry, and what challenges and new opportunities are opening up within the field.

The event, which will be held at the Hyatt Regency Irvine, Calif., on December 10, from 4 p.m. to 8 p.m. EST, will focus on how medical device makers will change the future of treating chronic diseases, as well as the opportunities for businesses to solve those problems. The event welcomes an incredible panel of industry leaders and executives, each of whom has left their own important mark on the medical device industry.

Featured speakers include:

  • Rick Altinger, CEO of Glooko. Mr. Altinger previously worked at Intuit, where he led the creation of the patient portal system; served as Executive Vice President at AdvancedMD, and was also an early employee at Healtheon/WebMD where he served as Vice President of Business Development.
  • Mark Carlson, Chief Medical Officer of St. Jude Medical. Carlson has chaired several policy committees and conferences sponsored by the Heart Rhythm Society and the FDA, as well as a task force that developed policy recommendations on pacemaker and ICD performance and industry communications.
  • Michael Farrell, CEO of ResMed. Farrell has served as the Company’s president – Americas since May 2011. He was previously senior vice president, strategic business unit – sleep from July 2007 to May 2011, and before that role he was vice president, marketing for the Americas from June 2005 through July 2007, and vice president, business development.
  • Dr. Robert Greenberg, CEO and Founder of Second sight, the creator of the world’s first bionic eye. Dr. Greenberg has worked in the field of retinal prosthetics for over twenty years. From 1991 to 1997, Dr. Greenberg conducted pre-clinical and clinical trials demonstrating the feasibility of retinal electrical stimulation to elicit visual perceptions. From 1997 to 1998, he served as a medical officer and lead reviewer for IDEs and 510(k)s at the Office of Device Evaluation at the U.S. Food and Drug Administration in the Neurological Devices Division.

Panel discussions with all the CEOs in attendance will be moderated by MassDevice publisher Brian Johnson and David Gollaher, President and CEO of the California Healthcare Institute.

“Chronic diseases represent the most critical market in medical technology,” MassDevice publisher Brian Johnson said. “Incredible innovation is taking place across the industry in how med tech both treats diseases such as diabetes, heart disease, COPD and sleep apnea. However, the future of med tech will be about managing the disease state, as well as treating it. This new paradigm will change the way devices and device companies interact with patients. In addition, changes in payment models from Obamacare will necessitate a new approach to the business model of this industry. We’re thrilled to welcome such an accomplished panel of leaders to discuss the future of the space.”

Covidien has underwritten the Big 100 West event, which is sponsored by aptitude, J29 Associates, KHJ Brand Activation, Porzio Life Sciences, Greenberg Traurig, HCB Health , and is partnered with the CHI. Additional support comes from OCTANe, BioCom, and AdvaMed 2014. All parties interested in attending the conference must register through the MassDevice Big 100 West EventBrite page.

About MassDevice:

MassDevice.com provides news and information for the medical device industry and the companies that drive it. Recognized throughout the med-tech industry as a go-to source for originally-reported, quality news coverage, MassDevice reaches more than 75,000 readers each month through its flagship website and email newsletters

Since 2009, MassDevice has been the online journal of the medical devices industry, with hour-to-hour coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11327191.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
2. Researchers capture first-ever images of atoms moving in a molecule
3. Life Technologies Moving "Off the Grid" with Clean Energy Fuel Cells
4. HIV-1 vaccine development: Pinning down a moving target
5. Removing the Risk in Risk-Based Monitoring, New Life Science Webinar Presented by Xtalks
6. Removing Barriers: L.A. Philanthropist Elliott Broidy Gives Top Performing Inner City High School Kids Opportunity to Attend Elite Stem Cell Camp
7. Natural Acne Remedy, Probiotic Action Debunks Makeup Removing Myths
8. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
9. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
10. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
11. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a ... today announced that its board of directors has amended its shareholder ... March 27, 2017 to March 27, 2018. The amendment was not in ... Ltd. ... Sinovac Biotech Ltd. is a China -based biopharmaceutical ...
(Date:3/23/2017)... , ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become ... hosted corporate cooking challenges for companies around the world, such as Illumina, HP and Qualcomm, ... the reason for its increasing popularity is due to its new team building format, a ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
(Date:3/23/2017)... March 23, 2017  Agriculture technology company Cool Planet ... and note conversion to commercialize its Cool Terra and ... on developing products that are simultaneously profitable as well ... the last 18 months. This latest round of funding ... Partners. The company,s primary product, Cool ...
Breaking Biology Technology:
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... ANGELES , Feb. 28, 2017   Acuant ... verification software globally, announces significant enhancements to new and ... May 2016. New products include mobile and desktop Acuant ... DocX TM - a real time manual review ... core idScan® technology provides the fastest and most accurate ...
(Date:2/28/2017)... Februar 2017  EyeLock LLC, ein marktführendes Unternehmen im ... biometrische Lösung zur Iris-Erkennung auf der neuesten ... auf dem Mobile World Congress 2017 (27. ... Halle 3, Stand 3E10, vorstellen. ... Haven™ – eine Kombination aus Hardware, Software ...
Breaking Biology News(10 mins):